BMEA Biomea Fusion, Inc. - Common Stock
$1,39
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 5, 2026
52W-Spanne
$1–$3
24% of range
Analystenbewertung
BUY
13 analysts
Kursziel
$6
+368% upside
P/E (TTM)
-1.2
ROE
-216.6%
Nettogewinnmarge
-3326.0%
BMEA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$1.39
Marktkapitalisierung
$100M
P/E (TTM)
-1.2
EPS (TTM)
$-1.18
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-216.6%
Verschuldungsgrad
—
52W-Spanne
$1 – $3
BMEA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
$-1.18
2020-12-31
→
2025-12-31
Freier Cashflow
—
2021-12-31
→
2024-12-31
Margen
-3326.0%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
BMEA
Peer-Median
P/E (TTM)
-1.2
0.8
P/B (K/B)
3.4
5.5
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
BMEA
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-4494.7%
—
Net Profit Margin (Nettogewinnmarge)
-3326.0%
-3742.1%
ROA
-89.2%
-49.4%
ROE
-216.6%
-59.3%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
BMEA
Peer-Median
Current Ratio (Liquiditätsgrad)
5.2
4.9
Quick Ratio
5.0
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
BMEA
Peer-Median
Revenue YoY (Umsatz YoY)
-67.1%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
BMEA
Peer-Median
BMEA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
13 Analysten
- Starker Kauf 5 38,5%
- Kauf 6 46,2%
- Halten 1 7,7%
- Verkauf 1 7,7%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
6 Analysten · 2026-08-18
Median
$7.00
Mittelwert
$6.50
← Unter allen Zielen
$1.39
Tief
$4.00
Hoch
$9.00
Median-Ziel
$7.00
+403,6%
Mittelwert-Ziel
$6.50
+367,6%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.10%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.12 | $-0.23 | 0.11% |
| 31. März 2026 | $-0.17 | $-0.24 | 0.07% |
| 31. Dezember 2025 | $0.27 | $-0.26 | 0.53% |
| 30. September 2025 | $-0.27 | $-0.26 | -0.01% |
| 30. Juni 2025 | $-0.51 | $-0.54 | 0.03% |
| 31. März 2025 | $-0.80 | $-0.62 | -0.18% |
| 31. Dezember 2024 | $-0.81 | $-0.94 | 0.13% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| BMEA | $90M | -1.1 | -67.1% | -3326.0% | -216.6% | — |
| XGN | $139M | -6.5 | 19.7% | -30.0% | -103.7% | 58.3% |
| COYA | $121M | -4.6 | 123.6% | -267.1% | -59.5% | — |
| CADL | $310M | -7.8 | — | — | -53.7% | — |
| ALDX | $312M | -9.2 | — | — | -68.0% | — |
| FBIO | — | — | — | — | — | — |
| GANX | $135M | -5.3 | -60.6% | — | -181.1% | — |
| RLYB | $4M | -0.4 | 34.9% | -1046.4% | -17.3% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 11
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $62M | $118M | $103M | $63M | $28M | $4M | |
| SG&A Expense | $19M | $26M | $24M | $21M | $14M | $2M | |
| Operating Expenses | $84M | $144M | $126M | $84M | $42M | $5M | |
| Operating Income | $-84M | $-144M | $-126M | $-84M | $-42M | $-5M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-62M | $-138M | $-117M | $-82M | $-42M | $-5M | |
| EPS (Basic) | $-1.18 | $-3.83 | $-3.44 | $-2.80 | $-1.74 | $-0.51 | |
| EPS (Diluted) | $-1.18 | $-3.83 | $-3.44 | $-2.80 | $-1.74 | $-0.51 | |
| Shares (Basic) | 52,228,068 | 36,105,671 | 34,106,923 | 29,271,777 | 23,858,552 | 10,532,942 | |
| Shares (Diluted) | 52,228,068 | 36,105,671 | 34,106,923 | 29,271,777 | 23,858,552 | 10,532,942 | |
| EBITDA | $-84M | $-144M | $-126M | $-84M | $-42M | · |
Bilanz 23
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $56M | $58M | $177M | $112M | $146M | $62M | |
| Short-term Investments | · | · | · | $1M | $28M | · | |
| Receivables | · | · | · | · | · | $16.0K | |
| Prepaid Expense | $2M | $10M | $2M | $5M | $3M | $528.0K | |
| Other Current Assets | · | · | · | · | · | $29.0K | |
| Current Assets | $58M | $68M | $179M | $118M | $177M | $62M | |
| PP&E (Net) | $153.0K | $4M | $5M | $6M | $3M | $81.0K | |
| PP&E (Gross) | $1M | $8M | $8M | $7M | $3M | $89.0K | |
| Accum. Depreciation | $1M | $4M | $2M | $916.0K | $257.0K | $8.0K | |
| Other Non-current Assets | $0 | $619.0K | $6M | $3M | $1M | $12.0K | |
| Total Assets | $59M | $80M | $200M | $129M | $186M | $63M | |
| Accounts Payable | $3M | $13M | $7M | $7M | $1M | $727.0K | |
| Accrued Liabilities | · | · | · | · | · | $633.0K | |
| Current Liabilities | $11M | $22M | $23M | $19M | $5M | $2M | |
| Capital Leases | $128.0K | $7M | $8M | $2M | $2M | · | |
| Total Liabilities | $29M | $28M | $31M | $21M | $7M | $2M | |
| Common Stock | $7.0K | $4.0K | $4.0K | $3.0K | $3.0K | $1.0K | |
| Paid-in Capital | $479M | $439M | $418M | $240M | $229M | $13M | |
| Retained Earnings | $-449M | $-387M | $-249M | $-132M | $-50M | $-8M | |
| AOCI | · | · | · | $-1.0K | $-10.0K | · | |
| Stockholders' Equity | $30M | $52M | $169M | $109M | $179M | $5M | |
| Liabilities + Equity | $59M | $80M | $200M | $129M | $186M | $63M | |
| Shares Outstanding | 72,299,440 | 36,310,713 | 35,866,610 | 29,561,554 | 29,115,421 | 11,953,107 |
Cashflow 9
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $10M | $19M | $14M | $10M | $6M | $322.0K | |
| Operating Cash Flow | $-70M | $-120M | $-97M | $-62M | $-35M | $-4M | |
| CapEx | · | $362.0K | $3M | $1M | $3M | $51.0K | |
| Investing Cash Flow | · | $-362.0K | $-2M | $27M | $-33M | $-51.0K | |
| Stock Issued | $5M | · | $162M | · | · | $10M | |
| Net Stock Activity | $5M | · | $162M | · | · | · | |
| Financing Cash Flow | $68M | $2M | $164M | $1M | $153M | $66M | |
| Net Change in Cash | $-2M | $-119M | $65M | $-34M | $84M | $61M | |
| Free Cash Flow | · | $-120M | $-100M | $-63M | $-39M | · |
Rentabilität 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -4494.7% | · | · | · | · | · | |
| Net Margin | -3326.0% | · | · | · | · | · | |
| EBITDA Margin | -4494.7% | · | · | · | · | · | |
| ROA | -89.2% | -98.9% | -71.2% | -51.9% | -33.5% | · | |
| ROE | -216.6% | -217.1% | -63.6% | -68.4% | -22.5% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 5.2 | 3.2 | 7.8 | 6.2 | 38.1 | · | |
| Quick Ratio | 5.0 | 2.7 | 7.7 | 5.9 | 37.4 | · |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · |
Wachstumsraten 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -67.1% | -36.4% | · | · | · | · |
Bewertung (TTM) 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-62M | $-138M | $-117M | $-82M | $-42M | · | |
| Market Cap | $90M | $141M | $521M | $249M | $217M | · | |
| P/E | -1.1 | -1.0 | -4.2 | -3.0 | -4.3 | · | |
| P/B | 3.0 | 2.7 | 3.1 | 2.3 | 1.2 | · | |
| P / Tangible Book | 3.0 | 2.7 | 3.1 | 2.3 | 1.2 | · | |
| P / Cash Flow | -1.3 | -1.2 | -5.4 | -4.0 | -6.1 | · | |
| P / FCF | · | -1.2 | -5.2 | -3.9 | -5.6 | · | |
| Earnings Yield | -95.2% | -98.7% | -23.7% | -33.2% | -23.4% | · |
Gewinn- und Verlustrechnung 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $165M | |
| R&D Expense | $9M | $9M | $8M | $14M | $17M | $23M | $25M | $27M | $32M | $34M | $31M | $25M | $22M | $24M | $21M | $18M | |
| SG&A Expense | $4M | $4M | $4M | $4M | $5M | $7M | $5M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $5M | |
| Operating Expenses | $13M | $13M | $12M | $21M | $21M | $30M | $30M | $34M | $39M | $41M | $37M | $31M | $28M | $30M | $26M | $23M | |
| Operating Income | $-13M | $-13M | $-12M | $-21M | $-21M | $-30M | $-30M | $-34M | $-39M | $-41M | $-37M | $-31M | $-28M | $-30M | $-26M | $-23M | |
| Net Income | $-8M | $-12M | $5M | $-16M | $-21M | $-29M | $-29M | $-33M | $-37M | $-39M | $-35M | $-28M | $-25M | $-29M | $-25M | $-23M | |
| EPS (Basic) | $-0.12 | $-0.17 | $0.40 | $-0.27 | $-0.51 | $-0.80 | $-0.80 | $-0.91 | $-1.03 | $-1.09 | $-0.96 | $-0.80 | $-0.70 | $-0.98 | $-0.87 | $-0.78 | |
| EPS (Diluted) | $-0.12 | $-0.17 | $0.40 | $-0.27 | $-0.51 | $-0.80 | $-0.80 | $-0.91 | $-1.03 | $-1.09 | $-0.96 | $-0.80 | $-0.70 | $-0.98 | $-0.87 | $-0.78 | |
| Shares (Basic) | 72,360,235 | 72,299,440 | -84,877,808 | 59,848,325 | 40,630,403 | 36,627,148 | -72,048,996 | 36,220,736 | 36,043,561 | 35,890,370 | -66,481,826 | 35,653,988 | 35,348,293 | 29,586,468 | -58,369,751 | 29,319,042 | |
| Shares (Diluted) | 72,360,235 | 72,299,440 | -84,877,808 | 59,848,325 | 40,630,403 | 36,627,148 | -72,048,996 | 36,220,736 | 36,043,561 | 35,890,370 | -66,481,826 | 35,653,988 | 35,348,293 | 29,586,468 | -58,369,751 | 29,319,042 | |
| EBITDA | $-13M | $-13M | · | $-21M | $-21M | $-30M | · | $-34M | $-39M | $-41M | · | $-31M | $-28M | $-30M | · | $-23M |
Bilanz 20
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $35M | $45M | $56M | $47M | $56M | $36M | $58M | $88M | $113M | $145M | $177M | $199M | $223M | $86M | $112M | $132M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Prepaid Expense | $1M | $1M | $2M | $3M | $8M | $9M | $10M | $6M | $3M | $3M | · | $3M | $3M | $3M | · | $5M | |
| Current Assets | $36M | $46M | $58M | $49M | $65M | $45M | $68M | $94M | $116M | $148M | · | $203M | $226M | $89M | · | $139M | |
| PP&E (Net) | $47.0K | $67.0K | $153.0K | $200.0K | $3M | $3M | $4M | $4M | $4M | $5M | · | $6M | $6M | $6M | · | $3M | |
| PP&E (Gross) | · | $668.0K | $1M | $1M | $8M | $8M | $8M | $8M | $8M | $8M | · | $8M | $8M | $8M | · | $4M | |
| Accum. Depreciation | · | $601.0K | $1M | $962.0K | $5M | $5M | $4M | $4M | $3M | $3M | · | $2M | $2M | $1M | · | $733.0K | |
| Other Non-current Assets | $398.0K | · | $0 | $0 | $4.0K | $617.0K | $619.0K | $5M | $7M | $7M | · | $5M | $4M | $4M | · | · | |
| Total Assets | $37M | $46M | $59M | $55M | $73M | $55M | $80M | $110M | $136M | $168M | · | $225M | $249M | $113M | · | $145M | |
| Accounts Payable | $3M | $5M | $3M | $6M | $8M | $8M | $13M | $9M | $6M | $5M | · | $3M | $4M | $5M | · | $2M | |
| Current Liabilities | $10M | $9M | $11M | $16M | $18M | $20M | $22M | $28M | $25M | $25M | · | $16M | $14M | $19M | · | $13M | |
| Capital Leases | $0 | $0 | $128.0K | $6M | $6M | $7M | $7M | $7M | $7M | $8M | · | $9M | $10M | $11M | · | $2M | |
| Total Liabilities | $25M | $28M | $29M | $40M | $46M | $26M | $28M | $34M | $32M | $33M | · | $25M | $24M | $30M | · | $14M | |
| Common Stock | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | · | $4.0K | $4.0K | $3.0K | · | $3.0K | |
| Paid-in Capital | $482M | $480M | $479M | $469M | $465M | $445M | $439M | $434M | $429M | $423M | · | $414M | $410M | $244M | · | $237M | |
| Retained Earnings | $-470M | $-461M | $-449M | $-454M | $-437M | $-417M | $-387M | $-358M | $-325M | $-288M | · | $-214M | $-186M | $-161M | · | $-106M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-13.0K | |
| Stockholders' Equity | $12M | $19M | $30M | $16M | $28M | $29M | $52M | $76M | $104M | $135M | $169M | $200M | $224M | $83M | $109M | $131M | |
| Liabilities + Equity | $37M | $46M | $59M | $55M | $73M | $55M | $80M | $110M | $136M | $168M | · | $225M | $249M | $113M | · | $145M | |
| Shares Outstanding | 72,483,852 | 72,299,440 | 72,299,440 | 59,508,518 | 58,127,256 | 37,572,250 | 36,310,713 | 36,238,280 | 36,184,485 | 35,933,586 | · | 35,698,847 | 35,630,276 | 29,651,134 | · | 29,388,753 |
Cashflow 9
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $5M | $5M | $5M | $4M | $4M | $3M | $3M | $3M | $3M | |
| Operating Cash Flow | $-10M | $-12M | $-14M | $-12M | $-19M | $-26M | $-30M | $-25M | $-33M | $-32M | $-23M | $-24M | $-26M | $-24M | $-20M | $-17M | |
| CapEx | · | · | · | $0 | $0 | $0 | $82.0K | $186.0K | $59.0K | $35.0K | $8.0K | $39.0K | $417.0K | $3M | $712.0K | $-50.0K | |
| Investing Cash Flow | $0 | $550.0K | · | $0 | $0 | $0 | $-82.0K | $-186.0K | $-59.0K | $-35.0K | $-8.0K | $-39.0K | $-417.0K | $-2M | $-701.0K | $225.0K | |
| Stock Issued | · | · | $-124.0K | $0 | $2M | $3M | · | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $3M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | · | · | $23M | $2M | $40M | $3M | $413.0K | $69.0K | $1M | $116.0K | $622.0K | $138.0K | $163M | $201.0K | $490.0K | $400.0K | |
| Net Change in Cash | $-10M | $-11M | $9M | $-10M | $20M | $-22M | $-30M | $-25M | $-32M | $-32M | $-22M | $-24M | $137M | $-26M | $-20M | $-16M | |
| Free Cash Flow | · | · | · | · | · | $-26M | · | · | · | $-32M | · | · | · | $-27M | · | · |
Rentabilität 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -4001.9% | -2970.7% | · | -473.1% | -3969.4% | -6602.7% | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -2610.7% | -2887.2% | · | -373.1% | -3869.4% | -6502.7% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -4001.9% | -2970.7% | · | -473.1% | -3969.4% | -6602.7% | · | · | · | · | · | · | · | · | · | · | |
| ROA | -15.1% | -24.5% | · | -19.8% | -19.8% | -26.2% | · | -19.5% | -19.4% | -27.8% | · | -15.4% | -12.1% | -20.2% | · | -13.3% | |
| ROE | -42.0% | -52.3% | · | -35.8% | -31.6% | -35.7% | · | -23.8% | -22.7% | -35.8% | · | -17.2% | -13.3% | -23.4% | · | -14.2% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 5.0 | · | 3.2 | 3.7 | 2.3 | · | 3.4 | 4.6 | 5.8 | · | 12.5 | 15.7 | 4.7 | · | 11.0 | |
| Quick Ratio | 3.3 | 4.8 | · | 3.0 | 3.2 | 1.8 | · | 3.2 | 4.5 | 5.7 | · | 12.3 | 15.5 | 4.6 | · | 10.6 |
Effizienz 1
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-58M | $-79M | · | $-96M | $-112M | $-129M | · | $-144M | $-140M | $-127M | · | $-108M | $-102M | $-95M | · | $-71M | |
| Market Cap | $107M | $111M | · | $120M | $105M | $80M | · | $366M | $163M | $537M | · | $491M | $782M | $919M | · | $287M | |
| P/E | -1.4 | -0.9 | · | -0.8 | -0.6 | -0.6 | · | -2.5 | -1.2 | -4.2 | · | -4.1 | -6.6 | -9.7 | · | -4.0 | |
| P/B | 8.8 | 5.9 | · | 7.7 | 3.8 | 2.8 | · | 4.8 | 1.6 | 4.0 | · | 2.5 | 3.5 | 11.1 | · | 2.2 | |
| P / Tangible Book | 8.8 | 5.9 | · | 7.7 | 3.8 | 2.8 | · | 4.8 | 1.6 | 4.0 | · | 2.5 | 3.5 | 11.1 | · | 2.2 | |
| P / Cash Flow | · | -9.5 | · | · | · | -3.1 | · | · | · | -16.8 | · | · | · | -38.2 | · | · | |
| P / FCF | · | · | · | · | · | -3.1 | · | · | · | -16.8 | · | · | · | -34.1 | · | · | |
| Earnings Yield | -72.8% | -114.4% | · | -118.3% | -168.3% | -166.7% | · | -39.7% | -86.7% | -23.9% | · | -24.3% | -15.1% | -10.3% | · | -24.9% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Betriebsgewinnmarge % | -4494.7% | — | — | — | — |
| Nettoergebnis | $-62M | $-138M | $-117M | $-82M | $-42M |
| Verwässerte EPS | $-1.18 | $-3.83 | $-3.44 | $-2.80 | $-1.74 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 5.2 | 3.2 | 7.8 | 6.2 | 38.1 |
| Quick Ratio | 5.0 | 2.7 | 7.7 | 5.9 | 37.4 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | — | $-120M | $-100M | $-63M | $-39M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 74 Einreicher · $27.3M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 11 (-3 vs. Vorquartal) | 14 (+6 vs. Vorquartal) | 22 (+5 vs. Vorquartal) | 10 (-6 vs. Vorquartal) | +4.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $7.170.501 | 4.877.892 | 26,29% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.159.993 | 2.829.927 | 15,25% | Aktien |
| Aisling Capital Management LP | $3.011.673 | 2.048.757 | 11,04% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $2.139.547 | 1.455.474 | 7,85% | Aktien |
| FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. | $1.063.069 | 723.176 | 3,90% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $900.720 | 612.735 | 3,30% | Aktien |
| Mariner, LLC | $874.247 | 594.726 | 3,21% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $864.837 | 588.010 | 3,17% | Aktien |
| JANE STREET GROUP, LLC | $673.685 | 458.289 | 2,47% | Aktien |
| XTX Topco Ltd | $598.112 | 406.879 | 2,19% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $585.795 | 398.500 | 2,15% | Kaufoption |
| TWO SIGMA INVESTMENTS, LP | $565.155 | 384.459 | 2,07% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $497.367 | 338.345 | 1,82% | Aktien |
| MARSHALL WACE, LLP | $443.938 | 301.999 | 1,63% | Aktien |
| MAI Capital Management | $424.977 | 289.100 | 1,56% | Aktien |
| STATE STREET CORP | $378.253 | 257.315 | 1,39% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $317.226 | 215.800 | 1,16% | Verkaufsoption |
| CITADEL ADVISORS LLC | $262.101 | 178.300 | 0,96% | Kaufoption |
| UBS Group AG | $198.848 | 135.271 | 0,73% | Aktien |
| NORTHERN TRUST CORP | $188.933 | 128.526 | 0,69% | Aktien |
| JANE STREET GROUP, LLC | $180.810 | 123.000 | 0,66% | Kaufoption |
| Headlands Technologies LLC | $163.683 | 111.349 | 0,60% | Aktien |
| Marex Group Ltd | $147.000 | 100.000 | 0,54% | Aktien |
| TWO SIGMA ADVISERS, LP | $131.192 | 105.800 | 0,48% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $124.362 | 84.600 | 0,46% | Aktien |
| LMR Partners LLP | $114.000 | 100.000 | 0,42% | Aktien |
| Jain Global LLC | $111.276 | 75.698 | 0,41% | Aktien |
| GRIFFIN ASSET MANAGEMENT, INC. | $87.906 | 59.800 | 0,32% | Aktien |
| SUPERSTRING CAPITAL MANAGEMENT LP | $85.306 | 250.000 | 0,31% | Aktien |
| Graham Capital Management, L.P. | $78.579 | 53.455 | 0,29% | Aktien |
| CITADEL ADVISORS LLC | $66.027 | 44.916 | 0,24% | Aktien |
| ADAR1 Capital Management, LLC | $63.827 | 43.420 | 0,23% | Aktien |
| Rathbones Group PLC | $54.390 | 37.000 | 0,20% | Aktien |
| Vanguard Global Advisers, LLC | $50.900 | 34.626 | 0,19% | Aktien |
| Point72 Asset Management, L.P. | $48.204 | 32.792 | 0,18% | Aktien |
| VANGUARD GROUP INC | $42.936 | 34.626 | 0,16% | Aktien |
| WOLVERINE TRADING, LLC | $36.462 | 17.700 | 0,13% | Kaufoption |
| Bank of New York Mellon Corp | $23.182 | 15.770 | 0,09% | Aktien |
| BlackRock, Inc. | $22.938 | 15.604 | 0,08% | Aktien |
| CFS Investment Advisory Services, LLC | $22.303 | 15.818 | 0,08% | Aktien |
| BIRCH FINANCIAL GROUP, LLC | $20.580 | 14.000 | 0,08% | Aktien |
| TWO SIGMA SECURITIES, LLC | $20.545 | 13.976 | 0,08% | Aktien |
| Point72 Asia (Singapore) Pte. Ltd. | $20.259 | 10.029 | 0,07% | Aktien |
| GOLDMAN SACHS GROUP INC | $19.580 | 13.320 | 0,07% | Aktien |
| CITADEL ADVISORS LLC | $19.404 | 13.200 | 0,07% | Verkaufsoption |
| Qube Research & Technologies Ltd | $18.668 | 12.699 | 0,07% | Aktien |
| PNC Financial Services Group, Inc. | $17.640 | 12.000 | 0,06% | Aktien |
| NewEdge Advisors, LLC | $17.640 | 12.000 | 0,06% | Aktien |
| Creative Planning | $17.640 | 12.000 | 0,06% | Aktien |
| OSAIC HOLDINGS, INC. | $15.876 | 10.800 | 0,06% | Aktien |
| FORTEM FINANCIAL GROUP, LLC | $14.700 | 10.000 | 0,05% | Aktien |
| MORGAN STANLEY | $13.193 | 8.975 | 0,05% | Aktien |
| HAP Trading, LLC | $11.160 | 24.800 | 0,04% | Kaufoption |
| FEDERATED HERMES, INC. | $11.003 | 7.485 | 0,04% | Aktien |
| SBI Securities Co., Ltd. | $10.425 | 7.092 | 0,04% | Aktien |
| Federation des caisses Desjardins du Quebec | $9.555 | 6.500 | 0,04% | Aktien |
| CITIGROUP INC | $6.906 | 4.698 | 0,03% | Aktien |
| HAP Trading, LLC | $6.820 | 24.800 | 0,03% | Kaufoption |
| Cubist Systematic Strategies, LLC | $6.805 | 3.369 | 0,02% | Aktien |
| SIGNATUREFD, LLC | $5.163 | 3.500 | 0,02% | Aktien |
| AlphaQuest LLC | $4.101 | 3.307 | 0,02% | Aktien |
| Rockefeller Capital Management L.P. | $2.940 | 2.000 | 0,01% | Aktien |
| Nuveen Asset Management, LLC | $2.281 | 588 | 0,01% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $1.548 | 1.053 | 0,01% | Aktien |
| BARCLAYS PLC | $1.405 | 956 | 0,01% | Aktien |
| Fortitude Family Office, LLC | $667 | 454 | 0,00% | Aktien |
| Global Retirement Partners, LLC | $551 | 375 | 0,00% | Aktien |
| Glen Eagle Advisors, LLC | $368 | 250 | 0,00% | Aktien |
| GSA CAPITAL PARTNERS LLP | $318 | 216.020 | 0,00% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $169 | 128 | 0,00% | Aktien |
| JPMORGAN CHASE & CO | $150 | 108 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $100 | 68 | 0,00% | Aktien |
| COMERICA BANK | $25 | 20 | 0,00% | Aktien |
| ROYAL BANK OF CANADA | $0 | 99 | 0,00% | Aktien |
Unternehmensinsider 12 Insider · 5 Führungskräfte · 8 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Michael J.M. Hitchcock | Interim CEO | 1. April 2026 A | 115.000 | 1 | 0 | $99.000 |
| Thomas Andrew Butler | Chief Executive Officer | 17. Januar 2024 A | — | 0 | 0 | $0 |
| Franco Valle | Chief Financial Officer | 30. November 2024 A | 42.995 | 0 | 0 | $0 |
| Rainer M Erdtmann | President, Chief Operating Officer, Principal Financial Officer, and Principal Accounting Officer | 1. April 2026 A | 723.027 | 3 | 0 | $97.400 |
| Juan Pablo Frias | Chief Medical Officer | 31. Mai 2024 A | 349 | 0 | 0 | $0 |
| Julianne Averill | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Sumita Ray | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Elizabeth Faust | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Eric Aguiar | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Sotirios Stergiopoulos | Direktor | 17. September 2021 P | 4.400.000 | 0 | 0 | $0 |
| Biomea Health, LLC | 10%-Eigentümer | 1. Juni 2022 J | 0 | 0 | 0 | $0 |
| A2A Pharmaceuticals, Inc. | 10%-Eigentümer | 17. September 2021 P | 4.400.000 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare GP III, LLC, Cormorant Asset Management, LP, Chen Bihua ×5 Einreichungen | 24. Oktober 2025 | 1,53% | Änderung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 3 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.